| Volume 31(2023) > Number 4 | 14.Acknowledgment of Reviewers | none | none |
| Volume 31(2023) > Number 4 | 15.Corrigendum to "SSR-based molecular diagnosis for Taiwan tea cultivars and its application in identifying cultivar composition of the processed tea" | Chih-Yi Hu, Hsien-Tsung Tsai, Chui-Feng Chiu, Tsung-Chen Su, Nguyen Hoang Khoi Le, Shu-Dan Yeh | none |
| Volume 31(2023) > Number 3 | 1.Effects of green tea–derived natural products on resistance exercise training in sarcopenia: A retrospective narrative mini-review | Hung-Wen Liu, Sue-Joan Chang | 381-386 |
| Volume 31(2023) > Number 3 | 2.How to deal with frenemy NRF2: Targeting NRF2 for chemoprevention and cancer therapy | Ya-Chu Tang, Yung-Jen Chuang, Hsin-Huei Chang, Shin-Hun Juang, Gow-Chin Yen, Jang-Yang Chang, Ching-Chuan Kuo | 387-407 |
| Volume 31(2023) > Number 3 | 3.Cannabis sativa L.: A comprehensive review on legislation, decriminalization, phytochemistry, antimicrobial activity, and safety | Mohammed Dalli, Salah-eddine Azizi, Ali Azghar, Abderrazak Saddari, Elmostapha Benaissa, Yassine Ben Lahlou, Mostafa Elouennass, Adil Maleb | 408-435 |
| Volume 31(2023) > Number 3 | 4.Determination and evaluation of EPA and DHA ethyl esters in fish oils using the TMAH transesterification method | Pai-Wen Wu, Ching-Hsuan Tsai, Ching-Yu Hsu, Shu-Han Chang, Ya-Min Kao, Su-Hsiang Tseng, Der-Yuan Wang | 436-445 |
| Volume 31(2023) > Number 3 | 5.SSR-based molecular diagnosis for Taiwan tea cultivars and its application in identifying cultivar composition of the processed tea | Chih-Yi Hu, Hsien-Tsung Tsai, Chui-Feng Chiu, Tsung-Chen Su, Nguyen Hoang Khoi Le, Shu-Dan Yeh | 446-457 |
| Volume 31(2023) > Number 3 | 6.Attenuation of diabetes-mediated muscle atrophy in rats by fish oil enriched omega-3 polyunsaturated fatty acids supplementation | Shing-Hwa Liu, Wei-Hsuan Lin, Huei-Ping Tzeng, Meng-Tsan Chiang | 458-472 |
| Volume 31(2023) > Number 3 | 7.An integrative approach for compressive quality control of RespireAid™, a traditional Chinese medicine formula against SARS-CoV-2 | Kun-Teng Wang, Chia-Jung Lee, Ming-Chung Lee, Chao-Yu Chen, Yun-Chen Tsai, Wu-Chang Chuang | 473-484 |
| Volume 31(2023) > Number 3 | 8. Cordycepin inhibits ERK pathway to suppress FGF9-induced tumorigenesis with MA-10 mouse Leydig tumor cells | Li-Ching Chen, Chin-Ying Chen, Yi-Ping Lee, Bu-Miin Huang | 485-501 |